In the treatment of kidney tumors, and especially in the minimally invasive removal of kidney tumors, the specialists at Döbling Private Hospital, such as Prof. Mesut Remzi, enjoy an excellent international reputation.
With a new type of minimally invasive procedure called "iTind", the Prostate Center at the Confraternität Private Hospital is expanding its range of treatments for benign prostate enlargement and bladder neck constriction.
Prostate cancer is the most common cancer in men. It is not always known why prostate cancer develops. One of the most important risk factors is age - 80% of affected men are over 60 years old, but also modern lifestyle and geographical factors (more common in the north than in the south). It has recently been shown that genetic predispositions (e.g. BRACA mutations) can also play a role, as in breast cancer. These patients are often younger and the cancer is often more aggressive. Men with a healthy Asian-influenced lifestyle are less likely to develop prostate cancer.
Today, many men are increasingly health-conscious, for example by paying attention to their diet or doing sports. Nevertheless, statistics show that generally seen they lead an unhealthier lifestyle than women, i.e. they consume more alcohol, smoke more often and eat less balanced.
Urinary incontinence may limit the mobility and social life of affected patients and thus severely affect their wellbeing. Confraternität Private Hospital has an excellent reputation for success in the treatment of male incontinence as well as other urological disorders.
Prostate cancer is the most common cancer in men and the number of cases is increasing worldwide. However, mortality from the disease has declined in recent decades. Early detection and an exact diagnosis are of crucial importance.
Confraternität Private Hospital has a focus on men’s health and offers a wide range of examinations and treatments especially for men from screening programs for the prevention of typical diseases to specific topics of urology, andrology (e.g. hormones, sexual dysfunction, incontinence, fertility problems, benign prostatic hyperplasia) and oncologic diseases, such as prostate cancer.
This website uses necessary cookies to ensure the functionality and security of the website. Provided that you have given your consent by ticking the respective checkbox, we also use non-essential cookies and similar technologies for statistical and analysis purposes. These help us to evaluate the online behavior of our visitors and thus to continuously improve our information offering. If you agree by ticking the respective checkbox, we also include content on this website that is provided via other websites, such as the PremiQaMed Group’s YouTube channel. In the process, we also use providers in third countries that are without an adequate level of data protection, in particular the United States. As a result, there is a possibility that the transferred data could be processed by local authorities and that you will not have an effective legal recourse against this. By checking the respective box or by clicking on “Agree to all”, you expressly agree that we or the providers (also located in third countries, in particular the United States) may use the aforementioned technologies to the full extent. For further information and the possibility to edit and change your settings at any time, please see our Data Protection Statement.
Protects against cross-site request forgery attacks.
Saves the display status of the notification popup.
Storage duration:
Variable
Technical name:
overlay
Saves the display status of the notification bar.
Storage duration:
1 year
Technical name:
promotion
For showing or hiding the Share bar.
Storage duration:
1 year
Technical name:
share_bar
Provider:
Tag management system from Google Inc.
Additional information as well as a notice about data transmission to third countries, in particular the United States, can be found in the section “Google Tag Manager” of our Data Protection Statement.
Provider:
Web analysis service from Google Inc.
Storage duration:
2 years, 2 years, session (current browsing session), 1 day
Technical name:
_ga,_ga_L3MEHLCG3J,_gid,_gat
Additional information as well as a notice about data transmission to third countries, in particular the United States, can be found in the section “Google Analytics” of our Data Protection Statement.
Provider:
Analysis tool from Meta Platforms Ireland Ltd.
Additional information as well as a notice about data transmission to third countries, in particular the United States, can be found in the section “Google Tag Manager” of our Data Protection Statement.
Provider:
Video service from YouTube LLC
Storage duration:
2 years, 6 months, session (current browsing session)
Technical name:
CONSENT,VISITOR_INFO1_LIVE,YSC
Additional information as well as a notice about data transmission to third countries, in particular the United States, can be found in the section “YouTube” of our Data Protection Statement.
Provider:
Map service from Google Inc.
Additional information as well as a notice about data transmission to third countries, in particular the United States, can be found in the section “Google Maps” of our Data Protection Statement.
1 possible transmission of data to the United States
